Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04445064
Title Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck. (HN1901)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cliniques universitaires Saint-Luc- Universite Catholique de Louvain
Indications

laryngeal squamous cell carcinoma

oropharynx cancer

oral squamous cell carcinoma

hypopharynx cancer

Therapies

IO102

IO103

Age Groups: senior | adult
Covered Countries BEL


No variant requirements are available.